Top Suppliers:I want be here



81733-79-1

81733-79-1 structure
81733-79-1 structure
  • Name: (D-Ala2)-Leu-Enkephalin-Arg trifluoroacetate salt
  • Chemical Name: (2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
  • CAS Number: 81733-79-1
  • Molecular Formula: C35H51N9O8
  • Molecular Weight: 725.83500
  • Catalog: Signaling Pathways GPCR/G Protein Opioid Receptor
  • Create Date: 2018-12-23 18:30:57
  • Modify Date: 2024-01-05 12:22:35
  • Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin-induced kidney injury. Dalargin shows antiulcer activity[1][2][3].

Name (2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
Synonyms Dalargin
H-Tyr-D-Ala-Gly-Phe-Leu-Arg-OH
(D-Ala2)-Leucine Enkephalin-Arg
Description Dalargin is a potent δ-opioid receptor agonist. Dalargin mitigates Gentamicin (HY-A0276)-induced cell death. Dalargin shows nephroprotective effects on Gentamicin-induced kidney injury. Dalargin shows antiulcer activity[1][2][3].
Related Catalog
Target

δ Opioid Receptor/DOR

In Vitro Dalargin (100 µg/mL; 1 h) 在体外减轻庆大霉素诱导的肾上皮细胞死亡[2]。 Cell Viability Assay[2] Cell Line: Kidney cells Concentration: 100 µg/mL Incubation Time: 1 h (prior to treatment with 1.2–2.5 mg/ml gentamicin for 24 h) Result: Reduced kidney cells death.
In Vivo Dalargin (25, 50 µg/kg; i.p.) 对庆大霉素诱导的大鼠肾损伤显示出肾脏保护作用[2]。 Animal Model: 290-350 g, White male rats[2] Dosage: 25, 50 µg/kg Administration: I.p. (3 h before each gentamicin injection) Result: Mitigated gentamicin-induced acutekidney injury, attenuated ROS generation and oxidative stress, alleviated histopathological changes in a renal tissue.
References

[1]. Titov MI, et al. Dalargin--a peptidnyĭ preparat s tsitoprotektivnym deĭstviem [Dalargin--a peptide preparation with cytoprotective action]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1985;8(2):72-6.  

[2]. Plotnikov EY, et al. Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicity. Toxicol Lett. 2013 Jul 18;220(3):303-8.  

[3]. Polonskiĭ VM, et al. Mesto prilozheniia (tsentral'noe ili perifericheskoe) protivoiazvennogo deĭstviia sinteticheskogo analoga éndogennykh opioidov dalargina v éksperimental'noĭ modeli tsisteaminovykh duodenal'nykh iazv u krys [The site (central or peripheral) of the anti-ulcer action of dalargin, a synthetic analog of endogenous opioids in an experimental model of cysteamine-induced duodenal ulcer in rats]. Biull Eksp Biol Med. 1987 Apr;103(4):433-4.  

Density 1.363g/cm3
Molecular Formula C35H51N9O8
Molecular Weight 725.83500
Exact Mass 725.38600
PSA 308.40000
LogP 5.06670
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.